WHO Launched Tuberculosis Research Toolkit
New guidance aims to include pregnant and lactating individuals in vital medical trials.
Updated on Oct. 13, 2026 in Asthma
Live Poll
Should medical research prioritize the inclusion of pregnant and breastfeeding women in clinical trials?
The World Health Organisation has released an online toolkit designed to improve the inclusion of pregnant and lactating women in tuberculosis research. This resource offers standardized guidance for trial design, pre-clinical studies, and pharmacokinetics during and after pregnancy.
Why it matters
Pregnant and lactating populations have historically been underrepresented in medical research. This exclusion creates significant evidence gaps that can delay access to life-saving medical innovations and optimal tuberculosis care for these individuals.
The toolkit provides a comprehensive framework for tuberculosis vaccine trials, focusing on trial design and pharmacokinetic data for pregnant and lactating women. It addresses the current lack of standardized research protocols for this demographic in clinical and pre-clinical settings.
The players
World Health Organisation
The international public health agency that directs and coordinates global health policy and research standards.
The details
The toolkit serves as an online resource to bridge systemic gaps in research methodology. It details how to incorporate pharmacokinetic assessments during and after pregnancy to ensure safety data is robust. By providing a structured approach to clinical trial design, the resource helps investigators manage the unique physiological considerations required for this specific patient group.
Timeline
October 12, 2026: The World Health Organisation launched the research toolkit.
Health Landscape
This release marks a significant departure from historical research patterns that frequently excluded pregnant and lactating individuals from trial cohorts. It aligns with broader global movements to modernize clinical trial inclusivity and ensure therapies are evaluated across diverse physiological states.
This toolkit primarily impacts the standards used by researchers and healthcare providers to develop safer, more effective treatments. If you are pregnant or lactating and considering participation in a clinical study, it is worth discussing the latest safety protocols and inclusion criteria with your doctor.
The takeaway
The lack of data on medical treatments during pregnancy often leaves patients and doctors without clear clinical guidance. Patients interested in how research updates affect their care should track whether their local health system adopts these international research standards.
Further reading
For more information on managing respiratory health conditions, visit our Asthma section.
Live Poll
Should medical research prioritize the inclusion of pregnant and breastfeeding women in clinical trials?
